Month: June 2022
-
Wyldeck takes a wilder approach
- 29 Jun 2022
This Janssen ANZ leader is changing the game when it comes to communications and public affairs, and he has built a top team to do it with.
Read more -
Bruce Goodwin finds his groove
- 27 Jun 2022
Over a year after he left a long and successful career at Janssen, this pharma statesman has a new sense of purpose, and of belonging.
Read more -
MA fills top senior roles
- 27 Jun 2022
Comms leader one of two new appointments as AZ, AbbVie and Gilead pick up new hires in the latest job movements.
Read more -
PBAC chair on Covid antivirals review
- 27 Jun 2022
Prof Wilson says PBS restrictions are unlikely to be the only factor impacting uptake of the pills.
Read more -
Health defines what a woman is
- 27 Jun 2022
It’s not a simple question to answer after all – or so the Federal Department of Health says.
Read more -
‘We are reading tea leaves,’ says Novavax SVP
- 24 Jun 2022
Med Affairs Head Dr Seth Toback tells MedNews about Novavax’s combo jab in Aussie trials, and how moving to ‘the dark side’ proved so rewarding.
Read more -
Moderna bivalent under TGA ‘rolling review’
- 24 Jun 2022
Regulator confirms the status of Moderna’s Omicron-targeting booster as its APAC Med Director presented new data in Sydney.
Read more -
Butler keeps industry advisory committee, for now
- 24 Jun 2022
Due to wrap-up next week, this high-powered committee of industry experts has once again been given an extension.
Read more








